Live News EQUITY FLASH L impact Nov 05, 2026, 03:08 PM UTC GSK kündigt neue Phase-II-Daten zu Efimosfermin bei MASH an Valid market news retained in the public archive without immediate LiveCast distribution. SquawkNews Desk